We previously reported that Lactoferrin (LF) could most likely be effective for preventing preterm delivery and intrauterine infections based on data derived from mice and rabbits. Here we describe six women with a history of multiple pregnancy losses or preterm delivery and refractory bacterial vaginosis, who received prebiotic LF therapy and delivered an infant normally. Five of the women were pregnant and one was not at the time of this study. The Ethics Committee at Showa University Hospital and Showa University Koto Toyosu Hospital approved the therapeutic protocol.
Abstract
We previously reported that Lactoferrin (LF) could most likely be effective for preventing preterm delivery and intrauterine infections based on data derived from mice and rabbits. Here we describe six women with a history of multiple pregnancy losses or preterm delivery and refractory bacterial vaginosis, who received prebiotic LF therapy and delivered an infant normally. Five of the women were pregnant and one was not at the time of this study. The Ethics Committee at Showa University Hospital and Showa University Koto Toyosu Hospital approved the therapeutic protocol.
Vaginal suppositories and oral prebiotic LF were administered to patients who were refractory to conventional treatment for vaginosis and had a history of late miscarriages and very early preterm delivery due to refractory vaginitis and chorioamnionitis.
Lactoferrin significantly improved the vaginal bacterial flora. Lactobacillus that was detectable in the vaginas of all patients after one month of LF therapy gradually became dominant.
The findings from these six patients suggest that administering LF to humans could help to prevent refractory vaginitis, cervical inflammation and preterm delivery.
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Introduction
Human milk and neutrophils contain large amounts of the glycoprotein LF which is a prebiotic in humans. LF also has been reported to be a biologic therapeutic protein for the treatment of diarrhea, inflammatory bowel diseases, anemia, wound healing, sepsis and cancer. We previously reported a high likelihood that LF could help to prevent preterm delivery and intrauterine infections in humans based on evidence derived from studies of mice and rabbits. [1] [2] [3] [4] Here, we describe six patients with a history of pregnancy losses or refractory bacterial vaginosis among whom five who were treated with LF throughout pregnancy proceeded to full term and delivered healthy infants normally. Cervical maturation related to preterm delivery did not arise and the bacterial flora of the vagina remained normal. Lactobacillus remained dominant throughout pregnancy and the course was uneventful with no adverse events affecting either the women or their infants.
Discussion
The rate of preterm delivery is 5.7% in Japan, which is one of the lowest among advanced countries and half that in the USA. Although the frequency of preterm labor is low in Japan, further efforts are underway to further reduce it. Rates of perinatal and early neonatal mortality continue to decrease in Japan, whereas those of preterm births are gradually increasing for reasons that remain unknown, although an increased frequency of maternal complications associated with having children later in life, myoma uteri, pregnancy-induced hypertension, other complications associated with aging and an increased need for in vitro fertilization and other reproductive techniques might be involved. Vaginal lavage has been linked to an increasing risk of PID. However, most of these reports describe vaginal lavage implemented by patients at home (Cottrell) , instead of in hospital, where lavage is usually administrated by medical staff in Japan. One report (Luong et al.) and our unpublished data have linked vaginal lavage to the extension of pregnancy among patients in preterm labor at MFICUs in Japan.
Many maternal or fetal genetic, endocrine and immune factors, stress and nutritional status are involved in preterm labor. Such factors can work alone or together to disrupt the mechanisms that maintain pregnancy and result in preterm delivery. Therefore, women at risk for preterm labor and birth should be identified during the first trimester.
Intrauterine infections might trigger preterm delivery in humans via locally produced cytokines such as interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α, which induce the production of cyclooxygenase (cox)-2, that in turn accelerates the production of prostaglandin (PG) E 2 and F 2 α. Such cascades ultimately cause ripening of the uterine cervical canal, the generation of uterine contractions and ultimately, preterm delivery (Romero et al. 1993) . We previously infused E. coli directly into the uterine cervical canals of rabbits to prepare models with a very similar etiology to that of 
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